Julian Hanak joins RecipharmCobra Biologics
This article was originally published in Scrip
Executive Summary
Biopharmaceuticals manufacturer RecipharmCobra Biologics has appointed Julian Hanak commercial director. Mr Hanak previously worked at the company's Keele facility for 11 years, progressing to director of production, though he most recently served as senior vice-president of development for Renovo. He has also worked for the National Institute for Medical Research, Bio Products Laboratory and AstraZeneca.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.